Kunkel Lori Anne Insider Trading
Get the latest insider transactions of Kunkel Lori Anne. Kunkel Lori Anne is Chief Medical Officer in PHARMACYCLICS INC ($PCYC) and Director in CURIS INC ($CRIS) and Acting-Chief Medical Officer in Tocagen Inc ($TOCA) and Director in Tocagen Inc ($TOCA) and Director in Loxo Oncology, Inc. ($LOXO) and Director in Oric Pharmaceuticals, Inc. ($ORIC). Discover the current value of Kunkel Lori Anne shares.
Address: C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE 94085CA
Kunkel Lori Anne is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
PCYC | PHARMACYCLICS INC | Chief Medical Officer | 2,842 | 730,678.20 |
LOXO | Loxo Oncology, Inc. | Director | 5,000 | 198,500.00 |
CRIS | CURIS INC | Director | 22,200 | 60,606.00 |
TOCA | Forte Biosciences, Inc. | Acting-Chief Medical Officer, Director | 0 | |
ORIC | Oric Pharmaceuticals, Inc. | Director | 0 |
Insider Trading Transactions of Kunkel Lori Anne
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | ORIC | Oric Pharmaceuticals, Inc ... | Kunkel Lori Anne | Director | Option Exercise | 19.03 | 16,625 | 316,374 | 16,625 |
Jun 10 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Kunkel Lori Anne | Director | Option Exercise | 35.92 | 28,515 | 1,024,259 | 28,515 |
Mar 04 2020 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | 1.26 | 180,000 | 226,800 | 180,000 |
Oct 04 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | 0.64 | 7,500 | 4,793 | 7,500 |
Oct 04 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | 0.64 | 7,500 | 4,793 | 7,500 |
May 31 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | 4.22 | 20,000 | 84,400 | 20,000 |
Feb 26 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Acting-Chief Medical ... | Option Exercise | 9.27 | 35,000 | 324,450 | 35,000 |
Feb 26 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Acting-Chief Medical ... | Option Exercise | 9.27 | 35,000 | 324,450 | 35,000 |
Feb 15 2019 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 3.65 | 27,344 | 99,751 | 0 |
Feb 15 2019 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 3.65 | 49,687 | 181,258 | 0 |
Feb 15 2019 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 20.91 | 4,716 | 98,612 | 0 |
Feb 15 2019 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 24.18 | 3,095 | 74,837 | 0 |
Feb 15 2019 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 78.58 | 11,000 | 864,380 | 0 |
Feb 15 2019 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 180.98 | 8,750 | 1,583,575 | 0 |
Jan 25 2019 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Sell | 1.05 | 14,800 | 15,581 | 22,200 |
Jan 23 2019 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | 1.16 | 180,000 | 208,800 | 180,000 |
Jan 23 2019 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | 1.16 | 180,000 | 208,800 | 180,000 |
Oct 03 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Buy | 3.65 | 5,000 | 18,240 | 5,000 |
Oct 03 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 170.20 | 4,500 | 765,881 | 500 |
Oct 03 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 171.90 | 500 | 85,948 | 0 |
Oct 03 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 3.65 | 5,000 | 18,240 | 22,344 |
Jun 25 2018 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | 8.98 | 20,000 | 179,600 | 20,000 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Buy | 3.65 | 27,343 | 99,747 | 34,183 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Buy | 20.91 | 3,096 | 64,737 | 37,279 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Buy | 24.18 | 1,953 | 47,224 | 39,232 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 180.28 | 28,440 | 5,127,024 | 10,792 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 181.48 | 2,411 | 437,544 | 8,381 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 182.35 | 1,541 | 280,996 | 6,840 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 175.64 | 1,235 | 216,920 | 5,605 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 177.12 | 5,601 | 992,059 | 4 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 177.79 | 4 | 711 | 0 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 3.65 | 27,343 | 99,747 | 27,344 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 20.91 | 3,096 | 64,737 | 4,716 |
Jun 18 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 24.18 | 1,953 | 47,224 | 5,859 |
Jun 14 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 180.98 | 8,750 | 1,583,575 | 8,750 |
Apr 24 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 131.98 | 900 | 118,779 | 10,940 |
Apr 24 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 132.81 | 4,000 | 531,239 | 6,940 |
Apr 24 2018 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 133.60 | 100 | 13,360 | 6,840 |
Jan 24 2018 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Buy | 0.00 | 185,000 | 0 | 185,000 |
Nov 06 2017 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 84.15 | 1,800 | 151,469 | 15,040 |
Nov 06 2017 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 85.21 | 2,800 | 238,591 | 12,240 |
Nov 06 2017 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 86.28 | 400 | 34,511 | 11,840 |
Aug 23 2017 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Sell | 75.17 | 10,000 | 751,731 | 16,840 |
Jun 23 2017 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 78.58 | 11,000 | 864,380 | 11,000 |
Apr 12 2017 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | 10.00 | 4,528 | 45,280 | 4,528 |
Mar 02 2017 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | 2.31 | 120,000 | 277,200 | 120,000 |
Nov 14 2016 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | 3.36 | 25,000 | 84,000 | 25,000 |
Jun 13 2016 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 24.18 | 7,812 | 188,894 | 7,812 |
Jul 30 2015 | LOXO | Loxo Oncology, Inc. | Kunkel Lori Anne | Director | Option Exercise | 20.91 | 7,812 | 163,349 | 7,812 |
May 01 2013 | PCYC | PHARMACYCLICS INC | Kunkel Lori Anne | Chief Medical Officer | Buy | 23.07 | 921 | 21,247 | 2,842 |
Nov 02 2012 | PCYC | PHARMACYCLICS INC | Kunkel Lori Anne | Chief Medical Officer | Buy | 23.07 | 921 | 21,247 | 1,921 |
Dec 05 2011 | PCYC | PHARMACYCLICS INC | Kunkel Lori Anne | Chief Medical Officer | Option Exercise | 14.92 | 300,000 | 4,476,000 | 300,000 |